New research provides a mechanistic map of how genetic mutations disrupt RNA splicing in acute myeloid leukemia.

The technology, called the Viral-Engineered RNA-based Activation System (VERAS), hijacks the virus's own replication ...

Scientists have long believed that RNA may have been the first molecule capable of storing information and evolving, a ...

Researchers have developed a new computational approach that uncovers possible drugs for specific cellular targets for ...

Treating acute myeloid leukemia (AML) depends on knowing what goes wrong inside cells. A new study suggests that two genetic ...

Ribo's IPO is aiming to raise around HKD 1.59 billion (around $205 million) through the sale of 27.5 million shares at HKD 57 ...

Bayer's Monsanto sued COVID-19 vaccine makers Pfizer, BioNTech and Moderna in Delaware federal court ​on Tuesday for ...

Japanese scientists have discovered a process by which RNA could have readily formed from a prebiotic environment on ancient ...

Aperture Therapeutics, a biotechnology company pioneering next-generation precision medicines for neurodegenerative diseases, today announced the advancement of its matrix metalloproteinase-9 (MMP9) ...

Bayer's Monsanto has sued Pfizer, BioNTech and Moderna, for allegedly misusing its messenger RNA technology in COVID vaccines ...

Treating acute myeloid leukemia (AML) depends on knowing what goes wrong inside cells. A new study suggests that two genetic ...

Pharmaceutical company Bayer has initiated lawsuits against several major COVID-19 vaccine manufacturers, including Pfizer, BioNTech, and Moderna, alleging unauthorized use of its messenger RNA (mRNA) ...